Donate now
EN

Director and her Team

IARC New Building

IARC Director Home

The Director of the International Agency for Research on Cancer (IARC) is responsible for the leadership of the Agency by providing: the general framework for attainment of the Agency’s mission in accordance with the IARC Statute, Rules and Regulations.


 

Portrait

Portrait of IARC Director for media use

Download portrait of IARC Director for media use (CC-BY-SA 3.0 IGO)
Download Photo 1
Download Photo 1 – ZIP file (higher resolution)
Download Photo 2

Photo credits
Photo 1: CC-BY-SA 3.0 IGO. IARC/M Stenmark
Photo 2: CC-BY-SA 3.0 IGO. IARC/M Sarzo
CC-BY-SA-IGO License information

Publications

Publications

Key Publications

27 April 2019 – Elisabete Weiderpass: charting a new course for IARC
16 May 2018 – A personal view on the role of IARC in cancer control

2025-2021
  1. Grenville ZS, Noor U, Rinaldi S, Gunter MJ, Ferrari P, Agnoli C, et al. (2025). Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 156(5): 943-952. https://doi.org/10.1002/ijc.35208 PMID: 39378119
  2. Reichmann R, Nimptsch K, Pischon T, Gunter MJ, Jenab M, Eriksen AK, et al. (2025). Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort. Int J Cancer. 156(5): 930-942. https://doi.org/10.1002/ijc.35205 PMID: 39511728
  3. Almanza-Aguilera E, Martinez-Huelamo M, Lopez-Hernandez Y, Guinon-Fort D, Guadall A, Cruz M, et al. (2024). Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study. Cancers (Basel). 16(23): 4116. https://doi.org/10.3390/cancers16234116 PMID: 39682302
  4. Beigrezaei S, Dianati M, Salehi-Abargouei A, Fararouei M, Akbari-Beni A, Brinkman M, et al. (2024). The association between animal protein, plant protein, and their substitution with bladder cancer risk: a pooled analysis of 10 cohort studies. Eur J Nutr. 64(1): 55. https://doi.org/10.1007/s00394-024-03551-3 PMID: 39718625
  5. Botteri E, Peveri G, Berstad P, Bagnardi V, Hoff G, Heath AK, et al. (2024). Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 39(2): 147-159. https://doi.org/10.1007/s10654-023-01059-4 PMID: 38180593
  6. Cariolou M, Christakoudi S, Gunter MJ, Key T, Perez-Cornago A, Travis R, et al. (2024). Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study. JNCI Cancer Spectr. 8(5): 12. https://doi.org/10.1093/jncics/pkae070 PMID: 39180334
  7. Cavalli F, Mikkelsen B, Weiderpass E, Sullivan R, Jaffray D, Gospodarowicz M (2024). World Oncology Forum amplifies its appeal in global fight against cancer. Lancet Oncol. 25(2): 170-174. https://doi.org/10.1016/S1470-2045(24)00010-X PMID: 38301688
  8. Deschasaux-Tanguy M, Huybrechts I, Julia C, Hercberg S, Sarda B, Fialon M, et al. (2024). Nutritional quality of diet characterized by the Nutri-Score profiling system and cardiovascular disease risk: a prospective study in 7 European countries. Lancet Reg Health Eur. 46: 101006. https://doi.org/10.1016/j.lanepe.2024.101006 PMID: 39529812
  9. Dicken SJ, Dahm CC, Ibsen DB, Olsen A, Tjonneland A, Louati-Hajji M, et al. (2024). Food consumption by degree of food processing and risk of type 2 diabetes mellitus: a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC). Lancet Reg Health Eur. 46: 101043. https://doi.org/10.1016/j.lanepe.2024.101043 PMID: 39529810
  10. Dobson AJ, Xu Z, Wilson LF, Chung HF, Sandin S, Van der Schouw YT, et al. (2024). Menopause age and type and dementia risk: a pooled analysis of 233 802 women. Age Ageing. 53(11): afae254. https://doi.org/10.1093/ageing/afae254 PMID: 39562342
  11. Fiolet T, Nicolas G, Casagrande C, Horvath Z, Frenoy P, Weiderpass E, et al. (2024). Dietary intakes of dioxins and polychlorobiphenyls (PCBs) and mortality: EPIC cohort study in 9 European countries. Int J Hyg Environ Health. 255: 114287. https://doi.org/10.1016/j.ijheh.2023.114287 PMID: 37989047
  12. Ghasemi-Kebria F, Fazel A, Semnani S, Etemadi A, Naeimi-Tabiei M, Hasanpour-Heidari S, et al. (2024). Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018. Cancer Epidemiol. 89: 102525. https://doi.org/10.1016/j.canep.2024.102525 PMID: 38228040
  13. Hadji M, Rashidian H, Marzban M, Rezaianzadeh A, Ansari-Moghaddam A, Bakhshi M, et al. (2024). Unveiling an Association between Waterpipe Smoking and Bladder Cancer Risk: A Multicenter Case-Control Study in Iran. Cancer Epidemiol Biomarkers Prev. 33(4): 509-515. https://doi.org/10.1158/1055-9965.EPI-23-0773 PMID: 38180357
  14. Hickey M, Basu P, Sassarini J, Stegmann ME, Weiderpass E, Nakawala Chilowa K, et al. (2024). Managing menopause after cancer. Lancet. 403(10430): 984-996. https://doi.org/10.1016/S0140-6736(23)02802-7 PMID: 38458217
  15. Li J, Roshelli Baker J, Aglago EK, Zhao Z, Jiao L, Freisling H, et al. (2024). Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients. Int J Cancer. 155(11): 1982-1995. https://doi.org/10.1002/ijc.35114 PMID: 39057841
  16. Liang C, Chung HF, Dobson A, Sandin S, Weiderpass E, Mishra GD (2024). Female reproductive histories and the risk of chronic obstructive pulmonary disease. Thorax. 79(6): 508-514. https://doi.org/10.1136/thorax-2023-220388 PMID: 38350732
  17. Liang C, Dobson AJ, Chung HF, van der Schouw YT, Sandin S, Weiderpass E, et al. (2024). Association of infertility and recurrent pregnancy loss with the risk of dementia. Eur J Epidemiol. 39(7): 785-793. https://doi.org/10.1007/s10654-024-01135-3 PMID: 38888679
  18. Macciotta A, Sacerdote C, Giachino C, Di Girolamo C, Franco M, van der Schouw YT, et al. (2024). Examining causal relationships between educational attainment and type 2 diabetes using genetic analysis: findings from the EPIC-InterAct study through Mendelian randomisation. J Epidemiol Community Health. https://doi.org/10.1136/jech-2024-222734 PMID: 39658133
  19. Matta K, Viallon V, Botteri E, Peveri G, Dahm C, Nannsen AO, et al. (2024). Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort. BMC Med. 22(1): 210. https://doi.org/10.1186/s12916-024-03362-7 PMID: 38807179
  20. Mayen AL, Sabra M, Aglago EK, Perlemuter G, Voican C, Ramos I, et al. (2024). Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study. BMC Med. 22(1): 221. https://doi.org/10.1186/s12916-024-03366-3 PMID: 38825687
  21. Mendes-Santos C, Nobrega C, Quinta-Gomes AL, Weiderpass E, Santana R, Andersson G (2024). Validation of the Portuguese version of the supportive care needs survey short-form questionnaire (SCNS-SF34-Pt) and the breast cancer supplementary module (SCNS-BR8-Pt). J Psychosoc Oncol. 42(4): 486-505. https://doi.org/10.1080/07347332.2023.2282015 PMID: 37975563
  22. Meng W, Leung JW, Wang Z, Li Q, Zhang L, Zhang K, et al. (2024). Safety of high-carbohydrate fluid diet 2 h versus overnight fasting before non-emergency endoscopic retrograde cholangiopancreatography: A single-blind, multicenter, randomized controlled trial. Chin Med J (Engl). 137(12): 1437-1446. https://doi.org/10.1097/CM9.0000000000002820 PMID: 37620294
  23. Morales-Berstein F, Biessy C, Viallon V, Goncalves-Soares A, Casagrande C, Hemon B, et al. (2024). Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis. Eur J Nutr. 63(2): 377-396. https://doi.org/10.1007/s00394-023-03270-1 PMID: 37989797
  24. O’Grady TJ, Rinaldi S, Michels KA, Adami HO, Buring JE, Chen Y, et al. (2024). Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis. Int J Epidemiol. 53(1). https://doi.org/10.1093/ije/dyad172 PMID: 38110618
  25. Peltonen J, Nikkila R, Al-Samadi A, Makitie A, Martinsen JI, Kjaerheim K, et al. (2024). Occupation and tongue cancer in Nordic countries. BMC Oral Health. 24(1): 506. https://doi.org/10.1186/s12903-024-04172-2 PMID: 38685000
  26. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Fedirko V, Wu K, et al. (2024). Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 154(9): 1596-1606. https://doi.org/10.1002/ijc.34830 PMID: 38200695
  27. Rashidian H, Hadji M, Ansari-Moghaddam A, Bakhshi M, Nejatizadeh A, Marzban M, et al. (2024). Association between waterpipe smoking and lung cancer: a multicentre case-control study in Iran. Public Health. 231: 166-172. https://doi.org/10.1016/j.puhe.2024.03.008 PMID: 38701659
  28. Rimal R, Robsahm TE, Green AC, Ghiasvand R, Rueegg CS, Bassarova A, et al. (2024). Trends in Invasive Melanoma Thickness in Norway, 1983-2019. Acta Derm Venereol. 104: adv26110. https://doi.org/10.2340/actadv.v104.26110 PMID: 39221835
  29. Ringborg U, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, et al. (2024). Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023. Mol Oncol. 18(2): 245-279. https://doi.org/10.1002/1878-0261.13575 PMID: 38135904
  30. Timmins IR, Jones ME, O’Brien KM, Adami HO, Aune D, Baglietto L, et al. (2024). International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 42(8): 927-939. https://doi.org/10.1200/JCO.23.01101 PMID: 38079601
  31. Tong TYN, Clarke R, Schmidt JA, Huybrechts I, Noor U, Forouhi NG, et al. (2024). Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries. Eur J Nutr. 63(1): 209-220. https://doi.org/10.1007/s00394-023-03251-4 PMID: 37804448
  32. Viallon V, Freisling H, Matta K, Nannsen AO, Dahm CC, Tjonneland A, et al. (2024). On the use of the healthy lifestyle index to investigate specific disease outcomes. Sci Rep. 14(1): 16330. https://doi.org/10.1038/s41598-024-66772-w PMID: 39009699
  33. Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, et al. (2024). BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 89: 102545. https://doi.org/10.1016/j.canep.2024.102545 PMID: 38377945
  34. Zheng JS, Steur M, Imamura F, Freisling H, Johnson L, van der Schouw YT, et al. (2024). Dietary intake of plant- and animal-derived protein and incident cardiovascular diseases: the pan-European EPIC-CVD case-cohort study. Am J Clin Nutr. 119(5): 1164-1174. https://doi.org/10.1016/j.ajcnut.2024.03.006 PMID: 38479550
  35. Ahimbisibwe A, Valberg M, Green AC, Ghiasvand R, Rueegg CS, Rimal R, et al. (2023). Nevus Count, Pigmentary Characteristics, and Melanoma-specific Mortality among Norwegian Women with Melanoma >1.0 mm Thick. Acta Derm Venereol. 103: adv4403. https://doi.org/10.2340/actadv.v103.4403 PMID: 37014267
  36. Ali M, Nusselder W, Weiderpass E, Corbex M, Bray F, Vaccarella S (2023). Inequities in cancer outcomes. Bull World Health Organ. 101(9): 550. https://doi.org/10.2471/BLT.23.290661 PMID: 37663873
  37. Allione A, Viberti C, Cotellessa I, Catalano C, Casalone E, Cugliari G, et al. (2023). Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort. Int J Cancer. 152(4): 725-737. https://doi.org/10.1002/ijc.34339 PMID: 36305648
  38. Almanza-Aguilera E, Guinon-Fort D, Perez-Cornago A, Martinez-Huelamo M, Andres-Lacueva C, Tjonneland A, et al. (2023). Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study. Cancers (Basel). 15(16). https://doi.org/10.3390/cancers15164067 PMID: 37627095
  39. Baumann M, Celis J, Ringborg U, Heitor M, Berns A, Albreht T, et al. (2023). Engaging European society at the forefront of cancer research and care: How discussions at the 5(th) Gago Conference on European Science policy led to the Heidelberg Manifesto: How discussions at the 5(th) Gago Conference on European Science policy led to the Heidelberg Manifesto. Mol Oncol. 17(6): 925-945. https://doi.org/10.1002/1878-0261.13423 PMID: 36938773
  40. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2023). Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 37(10): 2142-2142. https://doi.org/10.1038/s41375-023-01978-x PMID: 37666943
  41. Bonet C, Crous-Bou M, Tsilidis KK, Gunter MJ, Kaaks R, Schulze MB, et al. (2023). The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study. Eur J Epidemiol. 38(5): 545-557. https://doi.org/10.1007/s10654-023-00979-5 PMID: 36988840
  42. Botteri E, Peveri G, Berstad P, Bagnardi V, Chen SLF, Sandanger TM, et al. (2023). Changes in Lifestyle and Risk of Colorectal Cancer in the European Prospective Investigation Into Cancer and Nutrition. Am J Gastroenterol. 118(4): 702-711. https://doi.org/10.14309/ajg.0000000000002065 PMID: 36227801
  43. Castaneda J, Gil-Lespinard M, Almanza-Aguilera E, Llaha F, Gomez JH, Bondonno N, et al. (2023). Association between classes and subclasses of polyphenol intake and 5-year body weight changes in the EPIC-PANACEA study. Obesity (Silver Spring). 31(4): 1146-1158. https://doi.org/10.1002/oby.23689 PMID: 36693804
  44. Castro-Espin C, Bonet C, Crous-Bou M, Katzke V, Le Cornet C, Jannasch F, et al. (2023). Dietary patterns related to biological mechanisms and survival after breast cancer diagnosis: results from a cohort study. Br J Cancer. 128(7): 1301-1310. https://doi.org/10.1038/s41416-023-02169-2 PMID: 36737658
  45. Castro-Espin C, Bonet C, Crous-Bou M, Nadal-Zaragoza N, Tjonneland A, Mellemkjaer L, et al. (2023). Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study. BMC Med. 21(1): 225. https://doi.org/10.1186/s12916-023-02934-3 PMID: 37365585
  46. Christakoudi S, Tsilidis KK, Dossus L, Rinaldi S, Weiderpass E, Antoniussen CS, et al. (2023). A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort. BMC Cancer. 23(1): 562. https://doi.org/10.1186/s12885-023-11056-1 PMID: 37337133
  47. Chung FF, Maldonado SG, Nemc A, Bouaoun L, Cahais V, Cuenin C, et al. (2023). Buffy coat signatures of breast cancer risk in a prospective cohort study. Clin Epigenetics. 15(1): 102. https://doi.org/10.1186/s13148-023-01509-6 PMID: 37309009
  48. Chung HF, Dobson AJ, Hayashi K, Hardy R, Kuh D, Anderson DJ, et al. (2023). Ethnic Differences in the Association Between Age at Natural Menopause and Risk of Type 2 Diabetes Among Postmenopausal Women: A Pooled Analysis of Individual Data From 13 Cohort Studies. Diabetes Care. 46(11): 2024-2034. https://doi.org/10.2337/dc23-1209 PMID: 37747341
  49. Clasen JL, Mabunda R, Heath AK, Kaaks R, Katzke V, Schulze MB, et al. (2023). Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(14): 15588-15600. https://doi.org/10.1002/cam4.6207 PMID: 37269199
  50. Ersoy Guller Z, Harewood RN, Weiderpass E, Huybrechts I, Jenab M, Huerta JM, et al. (2023). Diet and lifestyle in relation to small intestinal cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 34(10): 927-937. https://doi.org/10.1007/s10552-023-01731-w PMID: 37330982
  51. Fontvieille E, Viallon V, Recalde M, Cordova R, Jansana A, Peruchet-Noray L, et al. (2023). Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies. BMC Med. 21(1): 418. https://doi.org/10.1186/s12916-023-03114-z PMID: 37993940
  52. Ghasemi-Kebria F, Jafari-Delouie N, Semnani S, Fazel A, Etemadi A, Norouzi A, et al. (2023). Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018. Cancer Epidemiol. 86: 102415. https://doi.org/10.1016/j.canep.2023.102415 PMID: 37442047
  53. Ghasemi-Kebria F, Semnani S, Fazel A, Etemadi A, Amiriani T, Naeimi-Tabiei M, et al. (2023). Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018. Int J Cancer. 153(1): 73-82. https://doi.org/10.1002/ijc.34518 PMID: 36943026
  54. Hadji M, Marzban M, Rashidian H, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2023). Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran. Acta Oncol. 62(12): 1661-1668. https://doi.org/10.1080/0284186X.2023.2276326 PMID: 37934078
  55. Heikkinen S, Demers PA, Hansen J, Jakobsen J, Kjaerheim K, Lynge E, et al. (2023). Incidence of cancer among Nordic police officers. Int J Cancer. 152(6): 1124-1136. https://doi.org/10.1002/ijc.34311 PMID: 36196485
  56. Karavasiloglou N, Hughes DJ, Murphy N, Schomburg L, Sun Q, Seher V, et al. (2023). Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts. Am J Clin Nutr. 117(1): 33-45. https://doi.org/10.1016/j.ajcnut.2022.10.004 PMID: 36789942
  57. Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, et al. (2023). Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol. 84(1): 127-137. https://doi.org/10.1016/j.eururo.2023.04.020 PMID: 37210288
  58. Laakso L, Jokelainen P, Houe H, Skjerve E, Hansen J, Lynge E, et al. (2023). No Excess Cancer Risk among Veterinarians in Denmark, Finland, Iceland, Norway, and Sweden after the 1980s. Cancers (Basel). 15(16). https://doi.org/10.3390/cancers15164079 PMID: 37627107
  59. Lampousi AM, Carlsson S, Lofvenborg JE, Cabrera-Castro N, Chirlaque MD, Fagherazzi G, et al. (2023). Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case-cohort study. Diabetologia. 66(8): 1460-1471. https://doi.org/10.1007/s00125-023-05948-x PMID: 37301794
  60. Lecuyer L, Laouali N, Viallon V, Artaud F, Hebert JR, Shivappa N, et al. (2023). Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Clin Nutr. 42(7): 1115-1125. https://doi.org/10.1016/j.clnu.2023.05.012 PMID: 37271707
  61. Lukic M, Licaj I, Laaksonen MA, Weiderpass E, Borch KB, Rylander C (2023). The burden of colon cancer attributable to modifiable factors-The Norwegian Women and Cancer Study. Int J Cancer. 152(2): 195-202. https://doi.org/10.1002/ijc.34237 PMID: 36054722
  62. Macciotta A, Catalano A, Giraudo MT, Weiderpass E, Ferrari P, Freisling H, et al. (2023). Mediating Role of Lifestyle Behaviors in the Association between Education and Cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 32(1): 132-140. https://doi.org/10.1158/1055-9965.EPI-22-0777 PMID: 36306379
  63. Mafra A, Bardot A, Charvat H, Weiderpass E, Soerjomataram I, Fregnani J (2023). Cancer survival in the northwestern of Sao Paulo State, Brazil: A population-based study. Cancer Epidemiol. 83: 102339. https://doi.org/10.1016/j.canep.2023.102339 PMID: 36863216
  64. Mahamat-Saleh Y, Al-Rahmoun M, Severi G, Ghiasvand R, Veierod MB, Caini S, et al. (2023). Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC). Int J Cancer. 152(3): 348-362. https://doi.org/10.1002/ijc.34253 PMID: 36053839
  65. Mahamat-Saleh Y, Rinaldi S, Kaaks R, Biessy C, Gonzalez-Gil EM, Murphy N, et al. (2023). Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(11): 12668-12682. https://doi.org/10.1002/cam4.5896 PMID: 37096432
  66. Mao Z, Baker JR, Takeuchi M, Hyogo H, Tjonneland A, Eriksen AK, et al. (2023). Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients. Int J Cancer. 152(11): 2257-2268. https://doi.org/10.1002/ijc.34449 PMID: 36715363
  67. Mendes-Santos C, Campos T, Ferreira D, Weiderpass E, Santana R, Andersson G (2023). Breast Cancer Survivors’ Attitudes toward eMental Health: A Cross-Sectional Study. Healthcare (Basel). 11(13): 16. https://doi.org/10.3390/healthcare11131920 PMID: 37444755
  68. Meyer A, Dong C, Casagrande C, Chan SSM, Huybrechts I, Nicolas G, et al. (2023). Food Processing and Risk of Crohn’s Disease and Ulcerative Colitis: A European Prospective Cohort Study. Clin Gastroenterol Hepatol. 21(6): 1607-1616 e1606. https://doi.org/10.1016/j.cgh.2022.09.031 PMID: 36243353
  69. Perrier F, Robsahm TE, Ghiasvand R, Borch KB, Braaten T, Weiderpass E, et al. (2023). No association between physical activity and primary melanoma thickness in a cohort of Norwegian women. Br J Dermatol. 188(5): 670-690. https://doi.org/10.1093/bjd/ljac136 PMID: 36718120
  70. Rashidian H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, Marzban M, Mohebbi E, et al. (2023). Opium use and risk of lung cancer: A multicenter case-control study in Iran. Int J Cancer. 152(2): 203-213. https://doi.org/10.1002/ijc.34244 PMID: 36043555
  71. Schmidt JA, Huybrechts I, Overvad K, Eriksen AK, Tjonneland A, Kaaks R, et al. (2023). Protein and amino acid intakes in relation to prostate cancer risk and mortality-A prospective study in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(4): 4725-4738. https://doi.org/10.1002/cam4.5289 PMID: 36148781
  72. Schuz J, Espina C, Carvalho A, Maza M, Luciani S, Cazap E, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: A landmark for cancer prevention in the region. Cancer Epidemiol. 86 Suppl 1: 102453. https://doi.org/10.1016/j.canep.2023.102453 PMID: 37852730
  73. Sedlmeier AM, Viallon V, Ferrari P, Peruchet-Noray L, Fontvieille E, Amadou A, et al. (2023). Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study. Br J Cancer. 128(4): 594-605. https://doi.org/10.1038/s41416-022-02071-3 PMID: 36460776
  74. Spacirova Z, Kaptoge S, Garcia-Mochon L, Rodriguez Barranco M, Sanchez Perez MJ, Bondonno NP, et al. (2023). The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease. Eur J Health Econ. 24(7): 1033-1045. https://doi.org/10.1007/s10198-022-01533-y PMID: 36239877
  75. Tschiderer L, Peters SAE, van der Schouw YT, van Westing AC, Tong TYN, Willeit P, et al. (2023). Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women. J Am Heart Assoc. 12(18): e030280. https://doi.org/10.1161/JAHA.123.030280 PMID: 37681566
  76. Van Sloten T, Valentin E, Climie RE, Deraz O, Weiderpass E, Jouven X, et al. (2023). Association of Midlife Cardiovascular Health and Subsequent Change in Cardiovascular Health With Incident Cancer. JACC CardioOncol. 5(1): 39-52. https://doi.org/10.1016/j.jaccao.2022.11.015 PMID: 36875895
  77. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2023). Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int J Epidemiol. 52(1): 71-86. https://doi.org/10.1093/ije/dyac124 PMID: 35726641
  78. Wu Z, Trabert B, Guillemette C, Caron P, Bradwin G, Graubard BI, et al. (2023). Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank. Cancer Epidemiol Biomarkers Prev. 32(11): 1564-1571. https://doi.org/10.1158/1055-9965.EPI-23-0772 PMID: 37619591
  79. Yammine SG, Huybrechts I, Biessy C, Dossus L, Panico S, Sanchez MJ, et al. (2023). Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. BMC Cancer. 23(1): 159. https://doi.org/10.1186/s12885-023-10611-0 PMID: 36797668
  80. Zamora-Ros R, Cayssials V, Cleries R, Torrents M, Byrnes G, Weiderpass E, et al. (2023). Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach. Eur J Nutr. 62(1): 105-114. https://doi.org/10.1007/s00394-022-02953-5 PMID: 35907037
  81. Alcala K, Mariosa D, Smith-Byrne K, Nasrollahzadeh Nesheli D, Carreras-Torres R, Ardanaz Aicua E, et al. (2022). The relationship between blood pressure and risk of renal cell carcinoma. Int J Epidemiol. 51(4): 1317-1327. https://doi.org/10.1093/ije/dyac042 PMID: 35312764
  82. Al-Zalabani AH, Wesselius A, Yi-Wen Yu E, van den Brandt P, Grant EJ, White E, et al. (2022). Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international cohort studies. Clin Nutr. 41(5): 1122-1130. https://doi.org/10.1016/j.clnu.2022.03.020 PMID: 35413574
  83. Basu P, Carvalho AL, Almonte M, Chajes V, Weiderpass E (2022). Pulling the investment levers on implementation research in oncology. Lancet Oncol. 23(4): 451-452. https://doi.org/10.1016/S1470-2045(22)00025-0 PMID: 35358451
  84. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2022). Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 36(12): 2835-2844. https://doi.org/10.1038/s41375-022-01711-0 PMID: 36273105
  85. Bertrand KA, O’Brien KM, Wright LB, Palmer JR, Blot WJ, Eliassen AH, et al. (2022). Gestational diabetes and risk of breast cancer before age 55 years. Int J Epidemiol. 50(6): 1936-1947. https://doi.org/10.1093/ije/dyab165 PMID: 34458915
  86. Boot IWA, Wesselius A, Yu EYW, Brinkman M, van den Brandt P, Grant EJ, et al. (2022). Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies. Eur J Nutr. 61(5): 2397-2416. https://doi.org/10.1007/s00394-022-02805-2 PMID: 35129646
  87. Cairat M, Rinaldi S, Navionis AS, Romieu I, Biessy C, Viallon V, et al. (2022). Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort. BMC Med. 20(1): 118. https://doi.org/10.1186/s12916-022-02319-y PMID: 35430795
  88. Casalone E, Birolo G, Pardini B, Allione A, Russo A, Catalano C, et al. (2022). Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study. Cancers (Basel). 15(1): 15. https://doi.org/10.3390/cancers15010125 PMID: 36612122
  89. Cayssials V, Buckland G, Crous-Bou M, Bonet C, Weiderpass E, Skie G, et al. (2022). Inflammatory potential of diet and pancreatic cancer risk in the EPIC study. Eur J Nutr. 61(5): 2313-2320. https://doi.org/10.1007/s00394-022-02809-y PMID: 35091827
  90. Charvat H, Freisling H, Noh H, Gaudet MM, Gunter MJ, Cross AJ, et al. (2022). Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies. Cancer Epidemiol Biomarkers Prev. 31(2): 325-333. https://doi.org/10.1158/1055-9965.EPI-21-0688 PMID: 34782393
  91. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Cancer. 151(5): 708-716. https://doi.org/10.1002/ijc.34009 PMID: 35366005
  92. Cordova R, Mayen AL, Knaze V, Aglago EK, Schalkwijk C, Wagner KH, et al. (2022). Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study. Cancer Commun (Lond). 42(10): 1041-1045. https://doi.org/10.1002/cac2.12343 PMID: 35924960
  93. Dam V, Onland-Moret NC, Burgess S, Chirlaque MD, Peters SAE, Schuit E, et al. (2022). Genetically Determined Reproductive Aging and Coronary Heart Disease: A Bidirectional 2-sample Mendelian Randomization. J Clin Endocrinol Metab. 107(7): e2952-e2961. https://doi.org/10.1210/clinem/dgac171 PMID: 35306566
  94. Dianatinasab M, Wesselius A, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, et al. (2022). Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. Int J Cancer. 151(1): 44-55. https://doi.org/10.1002/ijc.33970 PMID: 35182086
  95. Dimou N, Omiyale W, Biessy C, Viallon V, Kaaks R, O’Mara TA, et al. (2022). Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 31(9): 1839-1848. https://doi.org/10.1158/1055-9965.EPI-21-1176 PMID: 35900194
  96. Dong C, Chan SSM, Jantchou P, Racine A, Oldenburg B, Weiderpass E, et al. (2022). Meat Intake Is Associated with a Higher Risk of Ulcerative Colitis in a Large European Prospective Cohort Studyo. J Crohns Colitis. 16(8): 1187-1196. https://doi.org/10.1093/ecco-jcc/jjac054 PMID: 35396592
  97. Ellingjord-Dale M, Christakoudi S, Weiderpass E, Panico S, Dossus L, Olsen A, et al. (2022). Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Epidemiol. 50(6): 1914-1926. https://doi.org/10.1093/ije/dyab032 PMID: 34999853
  98. Fiolet T, Casagrande C, Nicolas G, Horvath Z, Frenoy P, Weiderpass E, et al. (2022). Dietary intakes of dioxins and polychlorobiphenyls (PCBs) and breast cancer risk in 9 European countries. Environ Int. 163: 107213. https://doi.org/10.1016/j.envint.2022.107213 PMID: 35364416
  99. Fortuin-de Smidt MC, Sewe MO, Lassale C, Weiderpass E, Andersson J, Huerta JM, et al. (2022). Physical activity attenuates but does not eliminate coronary heart disease risk amongst adults with risk factors: EPIC-CVD case-cohort study. Eur J Prev Cardiol. 29(12): 1618-1629. https://doi.org/10.1093/eurjpc/zwac055 PMID: 35403197
  100. Gaziano L, Sun L, Arnold M, Bell S, Cho K, Kaptoge SK, et al. (2022). Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses. Circulation. 146(20): 1507-1517. https://doi.org/10.1161/CIRCULATIONAHA.122.060700 PMID: 36314129
  101. Gil-Lespinard M, Castaneda J, Almanza-Aguilera E, Gomez JH, Tjonneland A, Kyro C, et al. (2022). Dietary Intake of 91 Individual Polyphenols and 5-Year Body Weight Change in the EPIC-PANACEA Cohort. Antioxidants (Basel). 11(12). https://doi.org/10.3390/antiox11122425 PMID: 36552633
  102. Grenville ZS, Noor U, His M, Viallon V, Rinaldi S, Aglago EK, et al. (2022). Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer. Nutrients. 14(16): 3306. https://doi.org/10.3390/nu14163306 PMID: 36014812
  103. Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2022). Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 51(3): 830-838. https://doi.org/10.1093/ije/dyac031 PMID: 35244716
  104. Harbs J, Rinaldi S, Gicquiau A, Keski-Rahkonen P, Mori N, Liu X, et al. (2022). Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case-Control Study and Meta-Analysis. Cancer Epidemiol Biomarkers Prev. 31(4): 793-803. https://doi.org/10.1158/1055-9965.EPI-21-0996 PMID: 35086823
  105. Hasanpour-Heidari S, Ahmadi A, Mansuri S, Qorbani A, Semnani S, Fazel A, et al. (2022). Development of an online cancer data collection and processing tool for population-based cancer registries in a low-resource setting: The CanDCap experience from Golestan, Iran. Int J Med Inform. 166: 104846. https://doi.org/10.1016/j.ijmedinf.2022.104846 PMID: 35981480
  106. Heath AK, Muller DC, van den Brandt PA, Critselis E, Gunter M, Vineis P, et al. (2022). Diet-wide association study of 92 foods and nutrients and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study. Int J Cancer. 151(11): 1935-1946. https://doi.org/10.1002/ijc.34211 PMID: 35830197
  107. Hosseini B, Olsson A, Bouaoun L, Hall A, Hadji M, Rashidian H, et al. (2022). Lung cancer risk in relation to jobs held in a nationwide case-control study in Iran. Occup Environ Med. 79(12): 831-838. https://doi.org/10.1136/oemed-2022-108463 PMID: 36379677
  108. Iglesias-Vazquez L, Arija V, Aranda N, Aglago EK, Cross AJ, Schulze MB, et al. (2022). Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study. Eur J Nutr. 61(1): 101-114. https://doi.org/10.1007/s00394-021-02625-w PMID: 34213605
  109. Iguacel I, Perez-Cornago A, Schmidt JA, Van Puyvelde H, Travis R, Casagrande C, et al. (2022). Evaluation of protein and amino acid intake estimates from the EPIC dietary questionnaires and 24-h dietary recalls using different food composition databases. Nutr Metab Cardiovasc Dis. 32(1): 80-89. https://doi.org/10.1016/j.numecd.2021.09.012 PMID: 34696945
  110. Kliemann N, Ould Ammar R, Biessy C, Gicquiau A, Katzke V, Kaaks R, et al. (2022). Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev. 31(7): 1359-1367. https://doi.org/10.1158/1055-9965.EPI-22-0160 PMID: 35437568
  111. Kohls M, Freisling H, Charvat H, Soerjomataram I, Viallon V, Davila-Batista V, et al. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1): 546. https://doi.org/10.1186/s12885-022-09589-y PMID: 35568802
  112. Lecuyer L, Laouali N, Dossus L, Shivappa N, Hebert JR, Agudo A, et al. (2022). Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Eur J Nutr. 61(7): 3625-3635. https://doi.org/10.1007/s00394-022-02897-w PMID: 35635567
  113. Liang C, Chung HF, Dobson AJ, Hayashi K, van der Schouw YT, Kuh D, et al. (2022). Infertility, recurrent pregnancy loss, and risk of stroke: pooled analysis of individual patient data of 618 851 women. BMJ. 377: e070603. https://doi.org/10.1136/bmj-2022-070603 PMID: 35732311
  114. Llaha F, Cayssials V, Farras M, Agudo A, Sandstrom M, Eriksen AK, et al. (2022). Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC study. Front Nutr. 9: 982369. https://doi.org/10.3389/fnut.2022.982369 PMID: 36118743
  115. Mafra da Costa A, Hernandes ICP, Weiderpass E, Soerjomataram I, Fregnani J (2022). Cancer Statistics over Time in Northwestern Sao Paulo State, Brazil: Incidence and Mortality. Cancer Epidemiol Biomarkers Prev. 31(4): 707-714. https://doi.org/10.1158/1055-9965.EPI-21-0842 PMID: 35131883
  116. Mayen AL, Viallon V, Botteri E, Proust-Lima C, Bagnardi V, Batista V, et al. (2022). A longitudinal evaluation of alcohol intake throughout adulthood and colorectal cancer risk. Eur J Epidemiol. 37(9): 915-929. https://doi.org/10.1007/s10654-022-00900-6 PMID: 36063305
  117. Mendes-Santos C, Nunes F, Weiderpass E, Santana R, Andersson G (2022). Development and Evaluation of the Usefulness, Usability, and Feasibility of iNNOV Breast Cancer: Mixed Methods Study. JMIR Cancer. 8(1): e33550. https://doi.org/10.2196/33550 PMID: 35166682
  118. Mendes-Santos C, Nunes F, Weiderpass E, Santana R, Andersson G (2022). Understanding Mental Health Professionals’ Perspectives and Practices Regarding the Implementation of Digital Mental Health: Qualitative Study. JMIR Form Res. 6(4): e32558. https://doi.org/10.2196/32558 PMID: 35412459
  119. Mukama T, Fortner RT, Katzke V, Hynes LC, Petrera A, Hauck SM, et al. (2022). Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. Br J Cancer. 126(9): 1301-1309. https://doi.org/10.1038/s41416-021-01697-z PMID: 35031764
  120. Nemati S, Saeedi E, Lotfi F, Nahvijou A, Mohebbi E, Ravankhah Z, et al. (2022). National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries. Int J Cancer. 151(12): 2128-2135. https://doi.org/10.1002/ijc.34224 PMID: 35869869
  121. Pakmanesh H, Anvari O, Forey N, Weiderpass E, Malekpourafshar R, Iranpour M, et al. (2022). TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. Int J Mol Sci. 23(22): 14319. https://doi.org/10.3390/ijms232214319 PMID: 36430798
  122. Papadimitriou N, Bouras E, van den Brandt PA, Muller DC, Papadopoulou A, Heath AK, et al. (2022). A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC. Clin Gastroenterol Hepatol. 20(4): 864-873 e813. https://doi.org/10.1016/j.cgh.2021.04.028 PMID: 33901663
  123. Peluso M, Munnia A, Russo V, Galli A, Pala V, Schouw YTV, et al. (2022). Cruciferous Vegetable Intake and Bulky DNA Damage within Non-Smokers and Former Smokers in the Gen-Air Study (EPIC Cohort). Nutrients. 14(12). https://doi.org/10.3390/nu14122477 PMID: 35745207
  124. Perrier F, Ghiasvand R, Lergenmuller S, Robsahm TE, Green AC, Borch KB, et al. (2022). Life-Course Trajectories of Physical Activity and Melanoma Risk in a Large Cohort of Norwegian Women. Clin Epidemiol. 14: 1571-1584. https://doi.org/10.2147/CLEP.S382454 PMID: 36578536
  125. Persson MSM, Yin W, Doring N, Risnes K, Weiderpass E, Steliarova-Foucher E, et al. (2022). Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study. Int J Cancer. 150(8): 1269-1280. https://doi.org/10.1002/ijc.33886 PMID: 34855204
  126. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Reichmann R, Wu K, et al. (2022). Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. Cancers (Basel). 14(22): 5499. https://doi.org/10.3390/cancers14225499 PMID: 36428592
  127. Porta M, Gasull M, Pumarega J, Kiviranta H, Rantakokko P, Raaschou-Nielsen O, et al. (2022). Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Int J Epidemiol. 51(2): 479-490. https://doi.org/10.1093/ije/dyab115 PMID: 34259837
  128. Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, et al. (2022). Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. J Clin Oncol. 40(31): 3613-3622. https://doi.org/10.1200/JCO.21.01785 PMID: 35700419
  129. Robinson N, Casement J, Gunter MJ, Huybrechts I, Agudo A, Barranco MR, et al. (2022). Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors. Br J Cancer. 127(2): 288-300. https://doi.org/10.1038/s41416-022-01792-9 PMID: 35354948
  130. Rothwell JA, Murphy N, Besevic J, Kliemann N, Jenab M, Ferrari P, et al. (2022). Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort. Clin Gastroenterol Hepatol. 20(5): e1061-e1082. https://doi.org/10.1016/j.cgh.2020.11.045 PMID: 33279777
  131. Smith-Byrne K, Cerani A, Guida F, Zhou S, Agudo A, Aleksandrova K, et al. (2022). Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiol Biomarkers Prev. 31(10): 1966-1974. https://doi.org/10.1158/1055-9965.EPI-21-1033 PMID: 35839461
  132. Stepien M, Lopez-Nogueroles M, Lahoz A, Kuhn T, Perlemuter G, Voican C, et al. (2022). Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma. Int J Cancer. 150(8): 1255-1268. https://doi.org/10.1002/ijc.33885 PMID: 34843121
  133. Taziki M, Rajaei S, Firouzei G, Hashemzadeh F, Rajabalian M, Mansoury M, et al. (2022). Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran. Cancer Epidemiol. 80: 102247. https://doi.org/10.1016/j.canep.2022.102247 PMID: 36081275
  134. Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, et al. (2022). Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). Int J Epidemiol. 51(3): e73-e86. https://doi.org/10.1093/ije/dyab211 PMID: 34652432
  135. Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, et al. (2022). Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 19(10): 656-673. https://doi.org/10.1038/s41571-022-00672-8 PMID: 36068272
  136. Veljkovikj I, Ilbawi AM, Roitberg F, Luciani S, Barango P, Corbex M, et al. (2022). Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews). Lancet Oncol. 23(10): e459-e468. https://doi.org/10.1016/S1470-2045(22)00387-4 PMID: 36174632
  137. Vissers LET, Sluijs I, Burgess S, Forouhi NG, Freisling H, Imamura F, et al. (2022). Milk intake and incident stroke and CHD in populations of European descent: a Mendelian randomisation study. Br J Nutr. 128(9): 1789-1797. https://doi.org/10.1017/S0007114521004244 PMID: 34670632
  138. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2022). Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia. Int J Cancer. 151(7): 1033-1046. https://doi.org/10.1002/ijc.34116 PMID: 35579976
  139. Wedekind R, Rothwell JA, Viallon V, Keski-Rahkonen P, Schmidt JA, Chajes V, et al. (2022). Determinants of blood acylcarnitine concentrations in healthy individuals of the European Prospective Investigation into Cancer and Nutrition. Clin Nutr. 41(8): 1735-1745. https://doi.org/10.1016/j.clnu.2022.05.020 PMID: 35779425
  140. Zhang L, Carvalho AL, Mosquera I, Wen T, Lucas E, Sauvaget C, et al. (2022). An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme. BMC Med. 20(1): 101. https://doi.org/10.1186/s12916-022-02291-7 PMID: 35317783
  141. Aglago EK, Mayen AL, Knaze V, Freisling H, Fedirko V, Hughes DJ, et al. (2021). Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Nutrients. 13(9). https://doi.org/10.3390/nu13093132 PMID: 34579010
  142. Aglago EK, Murphy N, Huybrechts I, Nicolas G, Casagrande C, Fedirko V, et al. (2021). Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Int J Cancer. 149(4): 865-882. https://doi.org/10.1002/ijc.33615 PMID: 33913149
  143. Aglago EK, Schalkwijk CG, Freisling H, Fedirko V, Hughes DJ, Jiao L, et al. (2021). Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study. Carcinogenesis. 42(5): 705-713. https://doi.org/10.1093/carcin/bgab026 PMID: 33780524
  144. Aleksandrova K, Reichmann R, Kaaks R, Jenab M, Bueno-de-Mesquita HB, Dahm CC, et al. (2021). Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score. BMC Med. 19(1): 1. https://doi.org/10.1186/s12916-020-01826-0 PMID: 33390155
  145. Alfonso JH, Martinsen JI, Weiderpass E, Pukkala E, Kjaerheim K, Tryggvadottir L, et al. (2021). Occupation and cutaneous melanoma: a 45-year historical cohort study of 14.9 million people in five Nordic countries. Br J Dermatol. 184(4): 672-680. https://doi.org/10.1111/bjd.19379 PMID: 33026672
  146. Anderson BO, Ilbawi AM, Fidarova E, Weiderpass E, Stevens L, Abdel-Wahab M, et al. (2021). The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases. Lancet Oncol. 22(5): 578-581. https://doi.org/10.1016/S1470-2045(21)00071-1 PMID: 33691141
  147. Arbyn M, Gultekin M, Morice P, Nieminen P, Cruickshank M, Poortmans P, et al. (2021). The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer. 148(2): 277-284. https://doi.org/10.1002/ijc.33189 PMID: 32638362
  148. Baker JR, Umesh S, Jenab M, Schomburg L, Tjonneland A, Olsen A, et al. (2021). Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations. Biomedicines. 9(11). https://doi.org/10.3390/biomedicines9111521 PMID: 34829750
  149. Barahona Ponce C, Scherer D, Brinster R, Boekstegers F, Marcelain K, Garate-Calderon V, et al. (2021). Gallstones, Body Mass Index, C-Reactive Protein, and Gallbladder Cancer: Mendelian Randomization Analysis of Chilean and European Genotype Data. Hepatology. 73(5): 1783-1796. https://doi.org/10.1002/hep.31537 PMID: 32893372
  150. Botteri E, Berstad P, Sandin S, Weiderpass E (2021). Lifestyle changes and risk of cancer: experience from the Swedish women’s lifestyle and health cohort study. Acta Oncol. 60(7): 827-834. https://doi.org/10.1080/0284186X.2021.1919756 PMID: 33988490
  151. Brancher S, Ribeiro AE, Toporcov TN, Weiderpass E (2021). The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials. J Cancer Res Clin Oncol. 147(10): 2819-2836. https://doi.org/10.1007/s00432-021-03728-x PMID: 34264392
  152. Brancher S, Stoer NC, Weiderpass E, Damhuis RAM, Johannesen TB, Botteri E, et al. (2021). Metformin use and lung cancer survival: a population-based study in Norway. Br J Cancer. 124(5): 1018-1025. https://doi.org/10.1038/s41416-020-01186-9 PMID: 33262518
  153. Bray F, Laversanne M, Cao B, Varghese C, Mikkelsen B, Weiderpass E, et al. (2021). Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4. Cancer Treat Rev. 100: 102290. https://doi.org/10.1016/j.ctrv.2021.102290 PMID: 34536729
  154. Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021). The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127(16): 3029-3030. https://doi.org/10.1002/cncr.33587 PMID: 34086348
  155. Butt J, Jenab M, Werner J, Fedirko V, Weiderpass E, Dahm CC, et al. (2021). Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort. Gut Microbes. 13(1): 1-14. https://doi.org/10.1080/19490976.2021.1903825 PMID: 33874856
  156. Castro-Espin C, Agudo A, Bonet C, Katzke V, Turzanski-Fortner R, Aleksandrova K, et al. (2021). Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. Eur J Epidemiol. 36(9): 953-964. https://doi.org/10.1007/s10654-021-00772-2 PMID: 34148186
  157. Christakoudi S, Pagoni P, Ferrari P, Cross AJ, Tzoulaki I, Muller DC, et al. (2021). Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 148(7): 1637-1651. https://doi.org/10.1002/ijc.33339 PMID: 33038275
  158. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2021). A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 114(1): 338-347. https://doi.org/10.1093/ajcn/nqab045 PMID: 33829249
  159. Cordova R, Kliemann N, Huybrechts I, Rauber F, Vamos EP, Levy RB, et al. (2021). Consumption of ultra-processed foods associated with weight gain and obesity in adults: A multi-national cohort study. Clin Nutr. 40(9): 5079-5088. https://doi.org/10.1016/j.clnu.2021.08.009 PMID: 34455267
  160. da Silva M, Laaksonen MA, Lissner L, Weiderpass E, Rylander C (2021). Preventable fractions of cancer incidence attributable to 7-years weight gain in the Norwegian Women and Cancer (NOWAC) study. Sci Rep. 11(1): 3800. https://doi.org/10.1038/s41598-021-83027-0 PMID: 33589669
  161. Darssan D, Mishra GD, Greenwood DC, Sandin S, Brunner EJ, Crawford SL, et al. (2021). Meta-analysis for individual participant data with a continuous exposure: A case study. J Clin Epidemiol. 140: 79-92. https://doi.org/10.1016/j.jclinepi.2021.08.033 PMID: 34487835
  162. Dashti SG, English DR, Simpson JA, Karahalios A, Moreno-Betancur M, Biessy C, et al. (2021). Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis. Cancer Epidemiol Biomarkers Prev. 30(1): 104-113. https://doi.org/10.1158/1055-9965.EPI-20-0965 PMID: 33008875
  163. Dianatinasab M, Wesselius A, de Loeij T, Salehi-Abargouei A, Yu EYW, Fararouei M, et al. (2021). The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies. Eur J Epidemiol. 36(8): 781-792. https://doi.org/10.1007/s10654-021-00762-4 PMID: 34036467
  164. Dimou N, Mori N, Harlid S, Harbs J, Martin RM, Smith-Byrne K, et al. (2021). Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 30(7): 1336-1348. https://doi.org/10.1158/1055-9965.EPI-20-1690 PMID: 33879453
  165. Dossus L, Kouloura E, Biessy C, Viallon V, Siskos AP, Dimou N, et al. (2021). Prospective analysis of circulating metabolites and endometrial cancer risk. Gynecol Oncol. 162(2): 475-481. https://doi.org/10.1016/j.ygyno.2021.06.001 PMID: 34099314
  166. Figueiredo RAO, Kajantie E, Neuvonen PJ, Rounge TB, Weiderpass E, Viljakainen H (2021). Lifetime antimicrobial use is associated with weight status in early adolescence-A register-based cohort study. Pediatr Obes. 16(3): e12727. https://doi.org/10.1111/ijpo.12727 PMID: 32959492
  167. Fuhrman BJ, Moore SC, Byrne C, Makhoul I, Kitahara CM, Berrington de Gonzalez A, et al. (2021). Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts. Cancer Res. 81(8): 2246-2255. https://doi.org/10.1158/0008-5472.CAN-19-3093 PMID: 33820799
  168. Ghasemi-Kebria F, Jafari-Delouie N, Amiriani T, Norouzi A, Abedi-Ardekani B, Nasrollahzadeh D, et al. (2021). Building a Cancer Biobank in a Low-Resource Setting in Northern Iran: the Golestan Cancer Biobank. Arch Iran Med. 24(7): 526-533. https://doi.org/10.34172/aim.2021.75 PMID: 34488317
  169. Ghiasvand R, Green AC, Sandanger TM, Weiderpass E, Robsahm TE, Veierod MB (2021). Phenotypic Characteristics and Melanoma Thickness in Women. Acta Derm Venereol. 101(4): adv00446. https://doi.org/10.2340/00015555-3806 PMID: 33880571
  170. group Sw, collaboration ESCCr (2021). SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 42(25): 2439-2454. https://doi.org/10.1093/eurheartj/ehab309 PMID: 34120177
  171. Hadji M, Rashidian H, Marzban M, Gholipour M, Naghibzadeh-Tahami A, Mohebbi E, et al. (2021). The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings. Arch Iran Med. 24(3): 167-176. https://doi.org/10.34172/aim.2021.27 PMID: 33878874
  172. Hanley-Cook GT, Huybrechts I, Biessy C, Remans R, Kennedy G, Deschasaux-Tanguy M, et al. (2021). Food biodiversity and total and cause-specific mortality in 9 European countries: An analysis of a prospective cohort study. PLoS Med. 18(10): e1003834. https://doi.org/10.1371/journal.pmed.1003834 PMID: 34662340
  173. Heath AK, Clasen JL, Jayanth NP, Jenab M, Tjonneland A, Petersen KEN, et al. (2021). Soft Drink and Juice Consumption and Renal Cell Carcinoma Incidence and Mortality in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 30(6): 1270-1274. https://doi.org/10.1158/1055-9965.EPI-20-1726 PMID: 33849969
  174. His M, Viallon V, Dossus L, Schmidt JA, Travis RC, Gunter MJ, et al. (2021). Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort. BMC Med. 19(1): 312. https://doi.org/10.1186/s12916-021-02183-2 PMID: 34886862
  175. Iguacel I, Schmidt JA, Perez-Cornago A, Van Puyvelde H, Travis R, Stepien M, et al. (2021). Associations between dietary amino acid intakes and blood concentration levels. Clin Nutr. 40(6): 3772-3779. https://doi.org/10.1016/j.clnu.2021.04.036 PMID: 34130023
  176. Jayasekara H, MacInnis RJ, Lujan-Barroso L, Mayen-Chacon AL, Cross AJ, Wallner B, et al. (2021). Lifetime alcohol intake, drinking patterns over time and risk of stomach cancer: A pooled analysis of data from two prospective cohort studies. Int J Cancer. 148(11): 2759-2773. https://doi.org/10.1002/ijc.33504 PMID: 33554339
  177. Jordan SJ, Na R, Weiderpass E, Adami HO, Anderson KE, van den Brandt PA, et al. (2021). Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium. Int J Cancer. 148(9): 2068-2078. https://doi.org/10.1002/ijc.33360 PMID: 33105052
  178. Julian-Serrano S, Yuan F, Wheeler W, Benyamin B, Machiela MJ, Arslan AA, et al. (2021). Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. 114(4): 1408-1417. https://doi.org/10.1093/ajcn/nqab217 PMID: 34258619
  179. Katzke VA, Le Cornet C, Mahfouz R, Brauer B, Johnson T, Canzian F, et al. (2021). Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures. Cancer Epidemiol Biomarkers Prev. 30(12): 2179-2187. https://doi.org/10.1158/1055-9965.EPI-21-0169 PMID: 34548327
  180. Laine JE, Huybrechts I, Gunter MJ, Ferrari P, Weiderpass E, Tsilidis K, et al. (2021). Co-benefits from sustainable dietary shifts for population and environmental health: an assessment from a large European cohort study. Lancet Planet Health. 5(11): e786-e796. https://doi.org/10.1016/S2542-5196(21)00250-3 PMID: 34688354
  181. Linseisen J, Grundmann N, Zoller D, Kuhn T, Jansen E, Chajes V, et al. (2021). Red Blood Cell Fatty Acids and Risk of Colorectal Cancer in The European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev. 30(5): 874-885. https://doi.org/10.1158/1055-9965.EPI-20-1426 PMID: 33619024
  182. Loftfield E, Stepien M, Viallon V, Trijsburg L, Rothwell JA, Robinot N, et al. (2021). Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality. J Natl Cancer Inst. 113(11): 1542-1550. https://doi.org/10.1093/jnci/djab078 PMID: 34010397
  183. Lofvenborg JE, Carlsson S, Andersson T, Hampe CS, Koulman A, Chirlaque Lopez MD, et al. (2021). Interaction Between GAD65 Antibodies and Dietary Fish Intake or Plasma Phospholipid n-3 Polyunsaturated Fatty Acids on Incident Adult-Onset Diabetes: The EPIC-InterAct Study. Diabetes Care. 44(2): 416-424. https://doi.org/10.2337/dc20-1463 PMID: 33303636
  184. Londono C, Cayssials V, de Villasante I, Crous-Bou M, Scalbert A, Weiderpass E, et al. (2021). Polyphenol Intake and Epithelial Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Antioxidants (Basel). 10(8). https://doi.org/10.3390/antiox10081249 PMID: 34439497
  185. Mao Z, Aglago EK, Zhao Z, Schalkwijk C, Jiao L, Freisling H, et al. (2021). Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer. Nutrients. 13(12): 4435. https://doi.org/10.3390/nu13124435 PMID: 34959986
  186. Matta M, Huybrechts I, Biessy C, Casagrande C, Yammine S, Fournier A, et al. (2021). Dietary intake of trans fatty acids and breast cancer risk in 9 European countries. BMC Med. 19(1): 81. https://doi.org/10.1186/s12916-021-01952-3 PMID: 33781249
  187. Mayen AL, Aglago EK, Knaze V, Cordova R, Schalkwijk CG, Wagner KH, et al. (2021). Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study. Int J Cancer. 149(4): 854-864. https://doi.org/10.1002/ijc.33612 PMID: 33899229
  188. Michels N, Specht IO, Heitmann BL, Chajes V, Huybrechts I (2021). Dietary trans-fatty acid intake in relation to cancer risk: a systematic review and meta-analysis. Nutr Rev. 79(7): 758-776. https://doi.org/10.1093/nutrit/nuaa061 PMID: 34104953
  189. Mohebbi E, Hadji M, Rashidian H, Rezaianzadeh A, Marzban M, Haghdoost AA, et al. (2021). Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 148(5): 1066-1076. https://doi.org/10.1002/ijc.33289 PMID: 32895947
  190. Moore A, Machiela MJ, Machado M, Wang SS, Kane E, Slager SL, et al. (2021). Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. J Transl Genet Genom. 5: 200-217. https://doi.org/10.20517/jtgg.2021.08 PMID: 34622145
  191. Papadimitriou N, Gunter MJ, Murphy N, Gicquiau A, Achaintre D, Brezina S, et al. (2021). Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies. Int J Cancer. 149(9): 1659-1669. https://doi.org/10.1002/ijc.33725 PMID: 34196970
  192. Perez-Cornago A, Crowe FL, Appleby PN, Bradbury KE, Wood AM, Jakobsen MU, et al. (2021). Plant foods, dietary fibre and risk of ischaemic heart disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Epidemiol. 50(1): 212-222. https://doi.org/10.1093/ije/dyaa155 PMID: 33245137
  193. Perrier F, Ghiasvand R, Lergenmuller S, Robsahm TE, Green AC, Borch KB, et al. (2021). Physical activity and cutaneous melanoma risk: A Norwegian population-based cohort study. Prev Med. 153: 106556. https://doi.org/10.1016/j.ypmed.2021.106556 PMID: 33862033
  194. Peters S, Broberg K, Gallo V, Levi M, Kippler M, Vineis P, et al. (2021). Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort. Ann Neurol. 89(1): 125-133. https://doi.org/10.1002/ana.25932 PMID: 33068316
  195. Pukkala E, Peltomaa M, Makitie A, Heikkinen S, Kjaerheim K, Martinsen JI, et al. (2021). Cancer incidence among musicians: 45 years of follow-up in four Nordic countries. Acta Oncol. 60(7): 835-841. https://doi.org/10.1080/0284186X.2021.1924403 PMID: 34162315
  196. Ried-Larsen M, Rasmussen MG, Blond K, Overvad TF, Overvad K, Steindorf K, et al. (2021). Association of Cycling With All-Cause and Cardiovascular Disease Mortality Among Persons With Diabetes: The European Prospective Investigation Into Cancer and Nutrition (EPIC) Study. JAMA Intern Med. 181(9): 1196-1205. https://doi.org/10.1001/jamainternmed.2021.3836 PMID: 34279548
  197. Ringborg U, Berns A, Celis JE, Heitor M, Tabernero J, Schuz J, et al. (2021). The Porto European Cancer Research Summit 2021. Mol Oncol. 15(10): 2507-2543. https://doi.org/10.1002/1878-0261.13078 PMID: 34515408
  198. Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, et al. (2021). Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Int J Cancer. 149(3): 594-605. https://doi.org/10.1002/ijc.33574 PMID: 33884608
  199. Saberi Hosnijeh F, Casabonne D, Nieters A, Solans M, Naudin S, Ferrari P, et al. (2021). Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis. Int J Cancer. 148(9): 2115-2128. https://doi.org/10.1002/ijc.33369 PMID: 33128820
  200. Singleton RK, Heath AK, Clasen JL, Scelo G, Johansson M, Calvez-Kelm FL, et al. (2021). Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 30(3): 507-512. https://doi.org/10.1158/1055-9965.EPI-20-1438 PMID: 33335022
  201. Stepien M, Keski-Rahkonen P, Kiss A, Robinot N, Duarte-Salles T, Murphy N, et al. (2021). Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study. Int J Cancer. 148(3): 609-625. https://doi.org/10.1002/ijc.33236 PMID: 32734650
  202. Steur M, Johnson L, Sharp SJ, Imamura F, Sluijs I, Key TJ, et al. (2021). Dietary Fatty Acids, Macronutrient Substitutions, Food Sources and Incidence of Coronary Heart Disease: Findings From the EPIC-CVD Case-Cohort Study Across Nine European Countries. J Am Heart Assoc. 10(23): e019814. https://doi.org/10.1161/JAHA.120.019814 PMID: 34796724
  203. Stoer NC, Botteri E, Busund M, Ghiasvand R, Vangen S, Lund E, et al. (2021). Menopausal hormone therapy and risk of melanoma: a population-based cohort study. Br J Dermatol. 185(6): 1266-1267. https://doi.org/10.1111/bjd.20640 PMID: 34254299
  204. Stoer NC, Botteri E, Thoresen GH, Karlstad O, Weiderpass E, Friis S, et al. (2021). Drug Use and Cancer Risk: A Drug-Wide Association Study (DWAS) in Norway. Cancer Epidemiol Biomarkers Prev. 30(4): 682-689. https://doi.org/10.1158/1055-9965.EPI-20-1028 PMID: 33144282
  205. van den Brandt PA, Ziegler RG, Wang M, Hou T, Li R, Adami HO, et al. (2021). Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies. Eur J Epidemiol. 36(1): 37-55. https://doi.org/10.1007/s10654-020-00688-3 PMID: 33128203
  206. Van Puyvelde H, Papadimitriou N, Clasen J, Muller D, Biessy C, Ferrari P, et al. (2021). Dietary Methyl-Group Donor Intake and Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Nutrients. 13(6): 15. https://doi.org/10.3390/nu13061843 PMID: 34071317
  207. Vineis P, Huybrechts I, Millett C, Weiderpass E (2021). Climate change and cancer: converging policies. Mol Oncol. 15(3): 764-769. https://doi.org/10.1002/1878-0261.12781 PMID: 32964631
  208. Wedekind R, Keski-Rahkonen P, Robinot N, Viallon V, Rothwell JA, Boutron-Ruault MC, et al. (2021). Pepper Alkaloids and Processed Meat Intake: Results from a Randomized Trial and the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Mol Nutr Food Res. 65(7): e2001141. https://doi.org/10.1002/mnfr.202001141 PMID: 33592132
  209. Weiderpass E (2021). Aménagement des villes et santé publique : une vision internationale. In: K. Georges, A. Vincent, S. Bosc, & O. Erik, editor.editors. Hippocrate et les territoires : perspectives pour la santé globale. ed.: Aube (Editions de l’); pp. 143-153.
  210. Wu Y, Huang R, Wang M, Bernstein L, Bethea TN, Chen C, et al. (2021). Dairy foods, calcium, and risk of breast cancer overall and for subtypes defined by estrogen receptor status: a pooled analysis of 21 cohort studies. Am J Clin Nutr. 114(2): 450-461. https://doi.org/10.1093/ajcn/nqab097 PMID: 33964859
  211. Yu EY, Wesselius A, Mehrkanoon S, Goosens M, Brinkman M, van den Brandt P, et al. (2021). Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study. BMC Med. 19(1): 56. https://doi.org/10.1186/s12916-021-01931-8 PMID: 33685459
  212. Zamora-Ros R, Lujan-Barroso L, Achaintre D, Franceschi S, Kyro C, Overvad K, et al. (2021). Blood polyphenol concentrations and differentiated thyroid carcinoma in women from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 113(1): 162-171. https://doi.org/10.1093/ajcn/nqaa277 PMID: 33021645
  213. Zheng JS, Luan J, Sofianopoulou E, Imamura F, Stewart ID, Day FR, et al. (2021). Plasma Vitamin C and Type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations. Diabetes Care. 44(1): 98-106. https://doi.org/10.2337/dc20-1328 PMID: 33203707

Highlights

Highlights

Office of the Director

Office of the Director

Read more


Close Reading Mode
UP